ClinicalTrials.gg
CompletedNCT01852877Updated Nov 15, 2019

Seek, Test, Treat, Retain: An Integrated Jail-Prison-Community Model for Illinois

An observational study in HIV Infections, sponsored by University of Illinois at Chicago. Completed at 3 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-11-15.

Sponsored by University of Illinois at Chicago · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
784
Ages
18 Years and older
Sex
All
01

Study summary

Aim-1: Evaluate opt-out versus opt-in testing for the human immunodeficiency virus (HIV) at the Cook County jail and the Illinois Department of Corrections Northern Intake facilities. Outcomes of interest include a) uptake of each HIV testing strategy, b) comparative effectiveness of identifying HIV-positive cases, new cases and undisclosed cases, and c) predictors of HIV testing.

Aim-2: Evaluate two case management strategies - "correctional case management" and "transitional case management" - designed to improve linkage and adherence to appropriate medical care after release from incarceration. Correctional case management is a longer-term, more intense approach while transitional case management seeks to meet the clients' immediate needs, link them to Ryan White case management, and then support the Ryan White case manager in assisting these clients. Correctional case management will be compared to the standard of care for jail detainees, and to transitional case management for persons leaving prison. Outcomes of interest include, (a) HIV viral load and CD4 cell counts over time, (b) adherence to medication, and (c) visits to medical providers.

Aim-3: Evaluate the impact of an incentive for HIV-positive detainees released from jail to visit an HIV service organization where they can be linked to medical care and case management. Outcomes of interest are essentially the same as Aim-2.

Aim-4: Assess university-based telemedicine as means to improve care of state prison inmates living with HIV. Outcomes of interest include medication regimens, HIV viral load and CD4 cell counts, and associated health conditions.

Aim-5: Assess the uptake of partner notification and social network HIV counseling and testing involving HIV-positive persons released from jail and prison as a means to extend the reach of the 'seek, test, treat and retain' (STTR) model into the community.

02

Conditions studied

  • HIV Infections

Keywords

  • HIV Diagnosis
  • Case Management
  • Telemedicine
  • Patient Compliance
  • Prisoners
03

In context

HIV Infections

4,342 studies on the registry are indexed under HIV Infections; 240 are open to participants now.

This study's enrollment of 784 is above the median of 200 across 731 observational studies indexed under HIV Infections.

Browse HIV Infections studies →

Lead sponsor

University of Illinois at Chicago is the lead sponsor of 523 studies on the registry; 132 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 19 (59%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Detainees in Cook County Jail, prisoners in the Illinois Department of Corrections

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • For assessing opt-out and opt-in HIV testing: all detainees in Cook County Jail and all prisoners in the Northern Intake facilities of the Illinois Department of Corrections (IDOC)
  • For assessing telemedicine: all HIV-positive IDOC prisoners who have received treatment for HIV. -- For assessing case management: all IDOC HIV telemedicine patients who have been released from prison and returned to Chicago in the past 60 days, and all known HIV-positive jail detainees likely to be returning the community (Chicago) within 60 days of contact with the jail's HIV clinic
  • For assessing a post-release incentive to visit an HIV service organization, and uptake of post-release partner notification and social network HIV testing: all former detainees participating in the case management evaluation

Exclusion criteria

Exclusion Criteria:

  • Less than 18 years old
  • Unable to speak English or Spanish
  • Incapable of providing informed consent
  • For jail detainees: being under extradition to a locale outside Cook County or a high likelihood of being sent to prison rather than being released to the community
  • For prison inmates: being under extradition to a locale outside Illinois
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
784 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Jail: HIV testing, corrections case mgt

    For all jail detainees regardless of HIV status, we observed the uptake of opt-out and opt-in HIV testing. For HIV-positive jail detainees leaving jail, we observed 1) health outcomes for corrections case management versus other than corrections case management, 2) the impact of an incentive to visit an HIV service organization after release from jail

    Behavioral: Corrections case management

  • Prison: telemed, corrections case mgt

    We compared outcomes for for HIV-positive prisoners before and after the implementation of telemedicine to deliver HIV medical care. For HIV-positive prisoners released from prison and returning to Chicago, we observed health outcomes for those enrolled in corrections case management those not enrolled in corrections case management.

    Behavioral: Corrections case management

Interventions

  • BehavioralCorrections case management

    Corrections case management is a long-term (18-24 months) program that seeks to improve the linkage of HIV-positive persons recently released from jail or prison to community-based HIV care, retain them in care, and reduce recidivism. Compared to the long-standing Ryan White case management program, corrections case management has greater access to housing and a greater emphasis on employment. Clients completing the program are then linked to the Ryan White case management program.

06

What researchers measure

Primary outcomes

  1. Change in HIV viral load

    Time frame: baseline and 6, 12, 18 months post-baseline

Secondary outcomes

  1. Change in CD4 cell count

    Time frame: baseline and 6, 12, 18 months post-baseline

  2. Change in community-level HIV viral load

    Time frame: baseline and 18 months post-baseline

Other outcomes

  1. Change in adherence to HIV medication

    Time frame: baseline and 6, 12, 18 months post-baseline

  2. Change in visits to HIV medical care provider

    Time frame: baseline and 6, 12, 18 months post-baseline

07

Study locations

3 sites
  • Illinois Department of Corrections
    Chicago, Illinois 60601, United States
  • University of Illinois at Chicago, School of Public Health, COIP
    Chicago, Illinois 60607, United States
  • Cermak Health Services, Cook County Jail
    Chicago, Illinois 60608, United States
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2013 to primary completion in Jun 2016, 35 months.

Of 183 non-industry observational studies under HIV Infections, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 69. This study's 35 months is close to that.

Counting every sponsor, half of 204 studies reached it within 38 months; a quarter within 17 and three quarters within 68.

How these figures are worked out, and which studies are left out of them.

Registered
May 8, 2013
First posted
May 14, 2013
StartActual
Jul 2013
Primary completionActual
Jun 30, 2016
CompletionActual
Jun 30, 2016
Last update
Nov 15, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 15, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01852877
Responsible party
Lawrence J. Ouellet, Ph.D. (Research Professor, University of Illinois at Chicago) — Principal investigator
First posted
May 14, 2013
Start date
Jul 2013
Primary completion
Jun 30, 2016
Completion
Jun 30, 2016
Last update
Nov 15, 2019

Study contacts

Lawrence J Ouellet, PhD
principal investigator · University of Illinois at Chicago
Jeremy D Young, MD
principal investigator · University of Illinois at Chicago
Chad Zawitz, MD
principal investigator · Cermak Health Services, Cook County
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion